John Johnson's Net Worth
Estimate Recalculated Jun 12, 2025 08:30PM EST
Who is John Johnson
John Johnson does not have any significant net worth to report based on the numbers we have. This is based on reported shares across multiple companies, which include Sucampo Pharmaceuticals, Inc., LILLY ELI & CO, SAVIENT PHARMACEUTICALS INC, CEMPRA, INC., HISTOGENICS CORP, Verastem, Inc., AVEO PHARMACEUTICALS INC, Xeris Biopharma Holdings, Inc., Axogen, Inc., Strongbridge Biopharma plc, DENDREON CORP, PORTOLA PHARMACEUTICALS INC, TRANZYME INC, and IMCLONE SYSTEMS INC.
SEC CIK
John Johnson's CIK is 0001410781
Past Insider Trading and Trends
2021 was John Johnson's most active year for acquiring shares with 18 total transactions. John Johnson's most active month to acquire stocks was the month of May. 2024 was John Johnson's most active year for disposing of shares, totalling 6 transactions. John Johnson's most active month to dispose stocks was the month of June. 2012 saw John Johnson paying a total of $18,960,030.16 for 2,113,207 shares, this is the most they've acquired in one year. In 2011 John Johnson cashed out on 500,000 shares for a total of $4,615,000.00, their largest year based on trade value.
Attention insiders:Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
